SFA · Sopharma AD
1.90
BGNUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
BGN997.44M
PE
28.40
EV/EBITDA
21.4
DIV Yield
1.8%
Payout Ratio
50%
MQV Rating
5Very Weak
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- HALO 100
- HALO 50
- HALO All
- Hammer Bearish
Key Fundamentals
EPS 3 yr Growth
92.80%
EBITDA Margin
7.60%
Operating Cashflow
€12m
Free Cash Flow Return
2.10%
ROIC
12.10%
Interest Coverage
6.80
Quick Ratio
0.70
Performance
52 weeks range
Low 1.21 - 2
Trade Value (12mth)
US$30,153.00
1 week
0%
1 month
-4.15%
YTD
29.37%
1 year
39.16%
All time high
3.78
Additional Data
Shares Outstanding (Fully Diluted)
551m
HALO Sector
Healthcare
Next Company Report Date
01-Feb-27
Next Ex Dividend Date
09-Jul-26
Next Dividend Pay Date
24-Aug-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
News & Announcements
No announcements available.